Data from TCGA databases suggested that SNHG4 expression was significantly correlated with the expression of RRM2, EZH2, AURKA and TK1 in prostate tumor samples (p < 0.01, Fig. 5c). Here, SNHG4 is linked to prostate neoplasm.